| Gene symbol | PMEL | Synonyms | D12S53E, HMB-45, HMB45, ME20, ME20-M, ME20M, P1, P100, PMEL17, SI, SIL, SILV, gp100 | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12q13.2 | dbXrefs | |
| Description | premelanosome protein | ||||
| Gene symbol | TYR | Synonyms | ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q14.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | tyrosinase | ||||
| GTO ID | GTC1325 |
| Trial ID | NCT00929019 |
| Disease | Uveal Melanoma |
| Altered gene | gp100|TYR |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | mRNA Transfected Dendritic Cell Vaccination |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | MRNA Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients |
| Year | 2009 |
| Country | Netherlands |
| Company sponsor | Radboud University Medical Center |
| Other ID(s) | NL22553.000.08|KUN2008-035 |
| Vector information | |||
|
|||
| Cohort1: dendritic cell vaccination | |||||||
|
|||||||
| Cohort2: No Intervention | |||||||
|
|||||||